Endoprosthesis market is expected to exhibit a significant growth in near future due to advancement in treatment, growing awareness for prosthetics in orthopedic injuries, increasing frequency of peripheral vascular diseases and orthopedic disorders. Knee and hip osteoarthritis prevalence is rising at rapid rate due to increase in number of higher age group population. However, in low and middle income countries have limited affordability and lack of healthcare coverage besides cultural hurdles. Endoprosthesis market has vast growth potential in terms of revenue aggravated by growing demand.
This report provides information on endoprosthesis market size for the year 2014-2016, and forecast of the same for year 2021. It also focuses on market drivers, challenges, restraints, market dynamics, growth indicators, competitive landscape, potential growth opportunities and other key aspects with respect to endoprosthesis solution market.
United States and Europe remain the potential market for endoprosthesis. Old age population in these countries is comparatively high coupled with the adoption of endoprosthesis. Awareness and insurance coverage among people are driving the market growth in these nations. India, China and few other countries in Asia Pacific region are slow growing markets for endoprosthesis due to issues like affordability, lack of insurance coverage and no support from government on regulations thus making the market to be dominated by few major players.
This report identifies endoprosthesis market on the basis of product types and regional market as follows:
Endoprosthesis market is segmented based on types of product such as wall stent endoprosthesis, biliary endoprosthesis, upper extremity prosthesis, lower extremity prosthesis and dental prosthesis
A detailed analysis by region – United States, Europe, Asia-Pacific (APAC) and Rest of the World (RoW), has also been provided in this report
This report looks into all the major companies operating in the endoprosthesis market. Some of the major companies’ profiles are as follows:
Zimmer Biomet Holdings Inc.
Smith & Nephew Plc.
Boston Scientific Inc.
Wright Medical Technology Inc.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. Endoprosthesis - Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis
4. Endoprosthesis - Market Forces
4.1.1. Ageing population
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Customers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. Endoprosthesis Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Endoprosthesis Market, By product type
6.1. Stent endoprosthesis
6.2. Biliary endoprosthesis
6.3. Upper extremity endoprosthesis
6.4. Lower extremity endoprosthesis
6.5. Dental endoprosthesis
7. Endoprosthesis Market, By Geography
7.2. North America
7.3.6. Rest of Europe
7.4. Asia Pacific
7.4.2. South Korea
7.4.5. Rest of Asia Pacific
8. Market Entropy
8.2. Technological Developments
8.3. Merger & Acquisitions, and Joint Ventures
8.4. Supply - Contract
9. Company Profiles (Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
9.1. Zimmer Biomet Holdings Inc.
9.2. Smith & Nephew Plc.
9.3. Stryker Corporation
9.4. Boston Scientific Inc.
9.5. Wright Medical Technology Inc.
9.6. BARD Peripheral Vascular
9.8. Gore medical
9.9. Fillauer LLC
9.10. Allard USA Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10.3. Research Methodology
10.4. Expert Insights